Logo

Power3, Mercy Women s Center Ink Breast Cancer Biomarker Deal

Sep 20, 2004

NEW YORK, Sept. 20 (GenomeWeb News) - Power3 Medical Products said today that it has signed an agreement to collaborate with Mercy Women's Center on the identification of protein biomarkers in blood serum that correlate to breast cancer.

 

Under this arrangement, Mercy Women's Center will provide Power3 with up to 600 blood serum samples from normal subjects and subjects with various stages of breast cancer. Additional terms of the deal were not disclosed.

 

Breaking News
The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.